clarithromycin has been researched along with Pyoderma Gangrenosum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korekawa, A; Nakajima, K; Nakano, H; Sawamura, D | 1 |
| Richter, JA; Seabrook, ME; Shmunes, E | 1 |
2 other study(ies) available for clarithromycin and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome.
Topics: Clarithromycin; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Pyoderma Gangrenosum | 2022 |
Pyroderma gangrenosum: resolution after treatment for Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Pyoderma Gangrenosum | 2006 |